How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,029 results for

Assistive Technology

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Assistive Technology ? Digital tools that involve social stimulation for mental health in later life

Assistive Technology ? Digital tools that involve social stimulation for mental health in later life Assistive Technology – Digital tools that involve social stimulation for mental health in later life We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Assistive Technology – Digital tools that involve social stimulation for mental health in later life (...) Evidence map Share: Reading time approx. 4 minutes Background Assistive technology includes digital tools and information technologies that aim to maintain or increase the security, activity, social participation, or independence of individuals who have or are at risk of developing mental ill health or impairments. Assistive technology overlaps with traditional adaptive technology as it includes compensatory and medical technologies designed to address a specific disability or medical condition

2018 Swedish Council on Technology Assessement

2. Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion

Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion Minimum standards for practices offering assisted reproductive technologies: a committee opinion PracticeCommitteeoftheAmericanSocietyforReproductiveMedicine,PracticeCommitteeoftheSocietyfor Assisted Reproductive Technology, and Practice Committee of the Society of Reproductive Biologists and Technologists American Society for Reproductive Medicine; Society for Assisted Reproductive (...) Technology; and Society of Reproductive Biologists and Technologists, Birmingham, Alabama Thisdocumentisdesignedtoprovideaframeworkforassistedreproductivetechnology(ART)programsthatmeetorexceedtherequire- mentssuggestedbytheCentersforDiseaseControlandPrevention(CDC)forcertificationofARTlaboratories.Thisdocumentreplaces the document, ‘‘Revised Minimum Standards for Practices Offering Assisted Reproductive Technologies: A Committee Opinion,’’ pub- lished in 2014. (Fertil Steril 2020;113:536–41.2019

2020 Society for Assisted Reproductive Technology

3. Assistive technology for memory support in dementia. Full Text available with Trip Pro

Assistive technology for memory support in dementia. The sustained interest in electronic assistive technology in dementia care has been fuelled by the urgent need to develop useful approaches to help support people with dementia at home. Also the low costs and wide availability of electronic devices make it more feasible to use electronic devices for the benefit of disabled persons. Information Communication Technology (ICT) devices designed to support people with dementia are usually referred (...) to as Assistive Technology (AT) or Electronic Assistive Technology (EAT). By using AT in this review we refer to electronic assistive devices. A range of AT devices has been developed to support people with dementia and their carers to manage their daily activities and to enhance safety, for example electronic pill boxes, picture phones, or mobile tracking devices. Many are commercially available. However, the usefulness and user-friendliness of these devices are often poorly evaluated. Although reviews

2017 Cochrane

4. Enhancing Equitable Access to Assistive Technologies in Canada

Enhancing Equitable Access to Assistive Technologies in Canada EVIDENCE BRIEF ENHANCING EQUITABLE ACCESS TO ASSISTIVE TECHNOLOGIES IN CANADA 8 JUNE 2017 Evidence Brief Enhancing Equitable Access to Assistive Technologies in Canada 20 June 2017 McMaster Health Forum 1 Evidence >> Insight >> Action Evidence Brief: Enhancing Equitable Access to Assistive Technologies in Canada 8 June 2017 McMaster Health Forum 2 Evidence >> Insight >> Action McMaster Health Forum For concerned citizens (...) priority assistive technologies’ coverage by province and territory. We are grateful to the Steering Committee members (Jerome Bickenbach, Amanda Grenier, Jeff Jutai, Don Juzwishin, Sandra MacLeod and Andria Spindel), and merit reviewers (Mark Harasymuk, John Rafferty, Paul Stolee, Chiranjeev Sanyal, Maggie MacNeil and Fay Wambolt) for providing feedback on previous drafts of the brief. The views expressed in the evidence brief should not be taken to represent the views of these individuals. Citation

2017 McMaster Health Forum

5. Progesterone (Lubion) - in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations

Progesterone (Lubion) - in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations Published 9 July 2018 Product Update: progesterone 25mg solution for injection (Lubion ® ) SMC2017 Pharmasure Ltd 8 June 2018 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use (...) in NHS Scotland. The advice is summarised as follows: ADVICE: following an abbreviated submission progesterone (Lubion ® ) is accepted for use within NHS Scotland. Indication under review: in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations. This increases the range of progesterone preparations available for use in NHS Scotland. Lubion ® is an aqueous formulation and may

2018 Scottish Medicines Consortium

6. Assistive technology - digital tools that involve social stimulation for mental health in later life

Assistive technology - digital tools that involve social stimulation for mental health in later life Assistive technology – digital tools that involve social stimulation for mental health in later life Assistive technology – digital tools that involve social stimulation for mental health in later life SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services Record Status This is a bibliographic record of a published health technology assessment from a member (...) of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services. Assistive technology – digital tools that involve social stimulation for mental health in later life. Stockholm: Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU). SBU Evidence Map. 2017 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Life

2017 Health Technology Assessment (HTA) Database.

7. Percutaneous ventricular assist devices: a health technology assessment

Percutaneous ventricular assist devices: a health technology assessment Percutaneous ventricular assist devices: a health technology assessment Percutaneous ventricular assist devices: a health technology assessment Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Percutaneous ventricular (...) assist devices: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario Health Technology Assessment Series; 17(2). 2017 Authors' conclusions On the basis of evidence of low to very low quality, Impella 2.5 devices were associated with improved hemodynamic stability, but had mortality rates and safety profile similar to IABPs in high-risk PCI and cardiogenic shock. Our cost-effectiveness analysis indicated that Impella 2.5 is likely associated with greater costs and fewer

2017 Health Technology Assessment (HTA) Database.

8. Technology-assisted rehabilitation following total knee or hip replacement for people with osteoarthritis: a systematic review and meta-analysis Full Text available with Trip Pro

Technology-assisted rehabilitation following total knee or hip replacement for people with osteoarthritis: a systematic review and meta-analysis Technology-assisted Rehabilitation Following Total Knee or Hip Replacement for People With Osteoarthritis: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History (...) be less than 100 characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation BMC Musculoskelet Disord Actions , 20 (1), 506 2019 Nov 3 Technology-assisted Rehabilitation Following Total Knee or Hip Replacement for People With Osteoarthritis: A Systematic Review and Meta-Analysis , , , , Affiliations Expand Affiliations 1 Level

2020 EvidenceUpdates

9. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. Full Text available with Trip Pro

International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. To report the utilization, effectiveness, and safety of practices in assisted reproductive technology (ART) globally in 2011 and assess global trends over time.Retrospective, cross-sectional survey on the utilization, effectiveness, and safety of ART procedures performed globally during 2011.Sixty-five countries and 2,560 ART clinics.Women and men undergoing ART (...) procedures.All ART.The ART cycles and outcomes on country-by-country, regional, and global levels. Aggregate country data were processed and analyzed based on methods developed by the International Committee for Monitoring Assisted Reproductive Technology (ICMART).A total of 1,115,272 ART cycles were reported for the treatment year 2011. Imputing data for nonreporting clinics, 1,643,912 cycles resulted in >394,662 babies, excluding People's Republic of China. The best estimate of global utilization including

2018 Fertility and Sterility

10. National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies. Full Text available with Trip Pro

National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies. To assess the attitudes of Society for Assisted Reproductive Technology (SART) members regarding expanding insurance coverage for patients seeking assisted reproductive technologies (ART) and identify some of the factors that may influence such attitudes.An anonymous online 14-question survey of SART membership; 1,556 surveys were sent through

2018 Fertility and Sterility

11. Assistive technology for children and young people with low vision. (Abstract)

Assistive technology for children and young people with low vision. Recent technological developments, such as the near universal spread of mobile phones and portable computers and improvements in the accessibility features of these devices, give children and young people with low vision greater independent access to information. Some electronic technologies, such as closed circuit TV, are well established low vision aids and newer versions, such as electronic readers or off-the shelf tablet (...) computers, may offer similar functionalities with easier portability and at lower cost.To assess the effect of electronic assistive technologies on reading, educational outcomes and quality of life in children and young people with low vision.We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2014, Issue 9), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to October 2014), EMBASE (January 1980

2015 Cochrane

12. Assisted reproductive technology: an overview of Cochrane Reviews. (Abstract)

Assisted reproductive technology: an overview of Cochrane Reviews. As many as one in six couples will encounter problems with fertility, defined as failure to achieve a clinical pregnancy after regular intercourse for 12 months. Increasingly, couples are turning to assisted reproductive technology (ART) for help with conceiving and ultimately giving birth to a healthy live baby of their own. Fertility treatments are complex, and each ART cycle consists of several steps. If one of the steps (...) is incorrectly applied, the stakes are high as conception may not occur. With this in mind, it is important that each step of the ART cycle is supported by good evidence from well-designed studies.To summarise the evidence from Cochrane systematic reviews on procedures and treatment options available to couples with subfertility undergoing assisted reproductive technology (ART).Published Cochrane systematic reviews of couples undergoing ART (in vitro fertilisation or intracytoplasmic sperm injection) were

2015 Cochrane

13. Culture media for human pre-implantation embryos in assisted reproductive technology cycles. (Abstract)

Culture media for human pre-implantation embryos in assisted reproductive technology cycles. Many media are commercially available for culturing pre-implantation human embryos in assisted reproductive technology (ART) cycles. It is unknown which culture medium leads to the best success rates after ART.To evaluate the safety and effectiveness of different human pre-implantation embryo culture media in used for in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) cycles.We

2015 Cochrane

14. Follitropin alfa (Bemfola) - Anovulation, assisted reproductive technologies, IVF

Follitropin alfa (Bemfola) - Anovulation, assisted reproductive technologies, IVF Final Appraisal Recommendation Advice No: 4114 – December 2014 Follitropin alfa (Bemfola ® ? ) 75 IU/0.125 ml, 150 IU/0.25 ml, 225 IU/0.375 ml, 300 IU/0.5 ml and 450 IU/0.75 ml solution for injection in a pre-filled pen Submission by Gedeon Richter (UK) Ltd Additional note(s): ? In accordance with EMA guidance, the licence for the use of follitropin alfa (Bemfola ® ? ) was granted on the basis of assumed (...) with clomiphene citrate; ? Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT); ? In association with a luteinising hormone (LH) preparation for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/l

2015 All Wales Medicines Strategy Group

15. An Assistive Technology System that Provides Personalized Dressing Support for People Living with Dementia: Capability Study Full Text available with Trip Pro

An Assistive Technology System that Provides Personalized Dressing Support for People Living with Dementia: Capability Study Individuals living with advancing stages of dementia (persons with dementia, PWDs) or other cognitive disorders do not have the luxury of remembering how to perform basic day-to-day activities, which in turn makes them increasingly dependent on the assistance of caregivers. Dressing is one of the most common and stressful activities provided by caregivers because of its (...) complexity and privacy challenges posed during the process.In preparation for in-home trials with PWDs, the aim of this study was to develop and evaluate a prototype intelligent system, the DRESS prototype, to assess its ability to provide automated assistance with dressing that can afford independence and privacy to individual PWDs and potentially provide additional freedom to their caregivers (family members and professionals).This laboratory study evaluated the DRESS prototype's capacity to detect

2018 JMIR medical informatics

16. Lessons from the pilot of a mobile application to map assistive technology suppliers in Africa Full Text available with Trip Pro

Lessons from the pilot of a mobile application to map assistive technology suppliers in Africa A pilot project to develop and implement a mobile smartphone application (App) that tracks and maps assistive technology (AT) availability in southern Africa was launched in Botswana in 2016. The App was developed and tested through an iterative process. The concept of the App (AT-Info-Map) was well received by most stakeholders within the pilot country, and broader networks. Several technical

2018 African journal of disability

17. Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology. Full Text available with Trip Pro

Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology. To examine outcomes of singleton pregnancies conceived without assisted reproductive technology (non-ART) compared with singletons conceived with ART by elective single-embryo transfer (eSET), nonelective single-embryo transfer (non-eSET), and double-embryo transfer with the establishment of 1 (DET -1) or ≥2 (DET ≥2) early fetal

2017 Fertility and Sterility

18. Computer-Assisted Virtual Surgical Technology Versus Three-Dimensional Printing Technology in Preoperative Planning for Displaced Three and Four-Part Fractures of the Proximal End of the Humerus. (Abstract)

Computer-Assisted Virtual Surgical Technology Versus Three-Dimensional Printing Technology in Preoperative Planning for Displaced Three and Four-Part Fractures of the Proximal End of the Humerus. This study aimed to determine the difference between computer-assisted virtual surgical technology and 3-dimensional (3D) printing technology in preoperative planning for proximal humeral fractures.Between February 2009 and October 2015, 131 patients with 3 and 4-part proximal humeral fractures were (...) ), a shorter time for preoperative planning (30.4 compared with 262.4 minutes; p < 0.001), and a decreased duration of hospital stay (10.9 compared with 14.6 days; p < 0.001).The clinical outcomes in both the virtual surgical and 3D printing groups were better than those in the conventional group. However, computer-assisted virtual surgical technology is more convenient and efficient, considering the shorter time for preoperative planning. In addition, it has improved correlation with preoperative

2018 The Journal of Bone and Joint Surgery. American Volume

19. Beliefs, attitudes and funding of assisted reproductive technology: Public perception of over 6,000 respondents from 6 European countries. Full Text available with Trip Pro

Beliefs, attitudes and funding of assisted reproductive technology: Public perception of over 6,000 respondents from 6 European countries. Fertility rates in Europe are among the lowest in the world, which may be attributed to both biological and lifestyle factors. Cost and reimbursement of fertility treatments vary across Europe, although its citizens enjoy wide access to fertility care. Since few regional studies evaluating public support for fertility treatment exist, we conducted

2019 PLoS ONE

20. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. Full Text available with Trip Pro

Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. To investigate the risks of ovarian, breast, and corpus uteri cancer in women who have had assisted reproduction.Large, population based, data linkage cohort study.All women who had assisted reproduction in Great Britain, 1991-2010, as recorded by the Human Fertilisation and Embryology (...) , or both. This study found no increased risk of any ovarian tumour in women treated because of only male factor or unexplained infertility.No increased risk of corpus uteri or invasive breast cancer was detected in women who had had assisted reproduction, but increased risks of in situ breast cancer and invasive and borderline ovarian tumours were found in this study. Our results suggest that ovarian tumour risks could be due to patient characteristics, rather than assisted reproduction itself

2018 BMJ

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>